Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-12002270Phase 4Completed
Phase 4, randomised, open-label trial of recombinant human interferon alpha-1b in viral pneumonia (4 arms), sponsored by Zhengzhou Children's Hospital. Primary endpoint: Clinical cure rate. Started Jan 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-12002270.